HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoru Noguchi Selected Research

Coloring Agents (Dyes)

1/2022Dermatomyositis: Muscle Pathology According to Antibody Subtypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoru Noguchi Research Topics

Disease

35Muscular Diseases (Myopathy)
04/2024 - 12/2004
13Nonaka type Distal myopathy
06/2014 - 03/2004
10Muscular Dystrophies (Muscular Dystrophy)
02/2017 - 03/2003
8Distal Myopathies (Distal Muscular Dystrophy)
01/2023 - 12/2004
6Muscle Weakness
01/2022 - 11/2009
5Scleroatonic muscular dystrophy
04/2024 - 09/2008
5Walker-Warburg Syndrome
09/2023 - 06/2004
5Muscular Atrophy (Muscle Atrophy)
01/2017 - 06/2009
4Dermatomyositis (Dermatopolymyositis)
01/2023 - 01/2020
4Malignant Hyperthermia
11/2022 - 06/2006
4Congenital Structural Myopathies (Centronuclear Myopathy)
06/2022 - 02/2015
4Necrosis
01/2022 - 03/2003
4Atrophy
01/2022 - 09/2008
3Myositis (Idiopathic Inflammatory Myopathies)
01/2023 - 01/2020
3Contracture
02/2022 - 01/2021
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2021 - 03/2003
3Limb-girdle muscular dystrophy type 2A
11/2014 - 05/2003
3Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
07/2007 - 05/2003
2Bethlem myopathy
04/2024 - 01/2021
2Inborn Genetic Diseases (Disease, Hereditary)
09/2023 - 01/2021
2Melanoma (Melanoma, Malignant)
01/2022 - 01/2020
2Fibrosis (Cirrhosis)
01/2021 - 02/2017
2Minicore Myopathy with External Ophthalmoplegia
01/2016 - 06/2006
2Central Core Myopathy (Central Core Disease)
06/2006 - 06/2006
1Antisynthetase syndrome
01/2023
1Inclusion Body Myositis
01/2023
1distal type 1 Arthrogryposis multiplex congenita
02/2022
1Neuronal intranuclear inclusion disease
01/2022
1Hypersensitivity (Allergy)
01/2022
1Sleep Apnea Syndromes (Sleep Apnea)
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Heat Stroke (Heatstroke)
01/2021
1Aspiration Pneumonia
01/2021

Drug/Important Bio-Agent (IBA)

17N-Acetylneuraminic Acid (Sialic Acid)IBA
12/2022 - 03/2004
13Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2003
9EnzymesIBA
10/2022 - 03/2004
6Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2022 - 06/2006
6Racemases and Epimerases (Epimerases and Racemases)IBA
02/2017 - 03/2004
6Uridine Diphosphate (UDP)IBA
02/2017 - 03/2004
6N-acylmannosamine kinaseIBA
05/2014 - 03/2004
5CollagenIBA
04/2024 - 09/2008
5Dystroglycans (Dystroglycan)IBA
11/2006 - 06/2004
3AntibodiesIBA
01/2023 - 11/2020
3UDP acetylglucosamine-2-epimeraseIBA
01/2022 - 11/2009
3Phosphotransferases (Kinase)IBA
02/2017 - 03/2004
3SugarsIBA
01/2012 - 03/2010
3LaminsIBA
06/2011 - 01/2009
3AcetylglucosamineIBA
11/2007 - 03/2004
2HLA-DR Antigens (HLA-DR)IBA
01/2023 - 01/2022
2Anesthetics (Anesthetic Agents)IBA
11/2022 - 06/2006
2Dynamin IIIBA
06/2022 - 01/2021
2Creatine Kinase (Creatine Phosphokinase)IBA
02/2022 - 01/2013
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2022 - 01/2021
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2022 - 01/2022
2Staphylococcal Protein A (Protein A)IBA
01/2022 - 01/2020
2UbiquitinIBA
01/2022 - 01/2020
2nuclear matrix protein 2IBA
01/2022 - 01/2020
2Alkaline PhosphataseIBA
01/2022 - 01/2021
2Mi-2 antibodiesIBA
01/2022 - 01/2021
2AutoantibodiesIBA
01/2021 - 01/2020
2LectinsIBA
08/2018 - 03/2004
2N,N-diacetylchitobioseIBA
02/2017 - 03/2004
2CalciumIBA
11/2016 - 06/2006
2DNA (Deoxyribonucleic Acid)IBA
04/2016 - 05/2015
2N-acetylneuraminoyllactoseIBA
10/2014 - 01/2012
2Messenger RNA (mRNA)IBA
06/2014 - 04/2007
2Amyloid beta-PeptidesIBA
06/2014 - 10/2008
2Glucosamine (Dona)IBA
05/2014 - 07/2012
2Choline KinaseIBA
10/2011 - 06/2011
2emerinIBA
06/2011 - 07/2007
2Amyloid (Amyloid Fibrils)IBA
11/2009 - 06/2009
2LipidsIBA
03/2009 - 08/2008
2Complementary DNA (cDNA)IBA
04/2007 - 03/2003
1Codon (Codons)IBA
09/2023
1DesminIBA
01/2023
1InterferonsIBA
01/2023
1Amino AcidsFDA Link
02/2022
1TropomyosinIBA
02/2022
1Troponin IIBA
02/2022
1Succimer (Dimercaptosuccinic Acid)FDA Link
01/2022
1transcriptional intermediary factor 1IBA
01/2022
1Coloring Agents (Dyes)IBA
01/2022
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2022
1Histone Deacetylases (Histone Deacetylase)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Nucleosomes (Nucleosome)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Caffeine (No Doz)FDA LinkGeneric
01/2021
1CationsIBA
01/2021
1DystrophinIBA
01/2021
1Halothane (Fluothane)FDA Link
01/2021
1Oxolinic AcidIBA
01/2021
1CDN1163IBA
01/2021

Therapy/Procedure

11Therapeutics
09/2023 - 01/2007
1Continuous Positive Airway Pressure
01/2022
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Cell Transplantation
01/2021
1Anesthesia
01/2021
1Transplantation
01/2021